Investment
Features
FeesSafety
Academy
More
Pluang+

Compare HCA Health Inc (HCA) vs Wynn Resorts, Limited (WYNN) Price & Performance

HCA Health IncTrade
Wynn Resorts, LimitedTrade

Price performance (Past 24H)

Key statistics

HCA Health Inc vs Wynn Resorts, Limited — how do they compare? HCA Health Inc trades at $450.18 (market cap $96.35B), while Wynn Resorts, Limited trades at $75.32 (market cap $7.75B). The key difference: HCA Health Inc is far larger — about 12.4× Wynn Resorts, Limited's market cap, and Wynn Resorts, Limited pays the higher dividend (1.33%). Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Wynn Resorts, Limited for 76 Days on average.

HCAWYNN
Market Cap
$96.35B$7.75B
Volume
1,079,4532,243,813
Sector
HealthConsumer Cyclical
52-Week High
$545.13$133.09
52-Week Low
$361.32$74.97
Typical Hold Time
76 Days76 Days
Enterprise Value
$146.88B$17.99B
Dividend Yield
0.7%1.33%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

HCA Health Inc

HCA Healthcare trades at $449.47, up 2.35% with bullish technical indicators and strong fundamental performance. The stock shows consistent earnings beats with Q2 2026 EPS of $7.59 exceeding expectations, while revenue growth continues from $75.6B in 2025 to projected $78.0B in 2026. Analyst consensus remains strongly positive with 63% buy ratings and $461.12 price target, though legal investigations present headwinds.

The outlook remains favorable with solid patient demand and operational efficiency driving growth, though investors should monitor ongoing legal investigations and debt levels. Valuation appears reasonable with P/E of 14.92 and EV/EBITDA of 9.26, while technical support at $440 provides near-term stability.

Wynn Resorts, Limited

Wynn Resorts (WYNN) trades at $75.24, up 0.36% with bearish technical signals from moving averages. The company reported mixed Q2 2026 earnings, beating EPS estimates but showing margin pressure in U.S. operations. Revenue growth is driven by Macau strength, while significant capital expenditures for new projects in the UAE create cash flow challenges. Analyst consensus remains strongly bullish with a $132.36 price target despite recent earnings volatility and high debt levels.

Investment outlook balances strong Macau recovery against rising capex risks. The stock offers 76% upside to consensus target but faces execution risks on new projects and persistent debt burden. Near-term catalysts include Q3 earnings and UAE project developments, while margin compression and economic sensitivity remain key concerns for investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HCA
1% Buy99% Sell
Avg holding period · 76 Days
WYNN

No sentiment data available yet.

Top news

Latest headlines on both assets

About HCA Health Inc

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.

Read more on HCA →

About Wynn Resorts, Limited

Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, Encore Boston Harbor in Massachusetts opened June 2019. Additionally, we expect the company to begin construction on a new building next to its existing Macao Palace resort in 2023, which we forecast to open in 2026. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and Las Vegas, respectively.

Read more on WYNN →